<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BB8CCC4E-498D-4876-8064-A5AD57294642"><gtr:id>BB8CCC4E-498D-4876-8064-A5AD57294642</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:otherNames>L</gtr:otherNames><gtr:surname>Bailey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190081961"><gtr:id>C8508946-7C19-49FE-B21E-BD2D7C168DFA</gtr:id><gtr:title>Identification of responses to CAP1 peptides in trachomatous subjects</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190081961</gtr:grantReference><gtr:abstractText>This work demonstrated the usefulness of studying host conjunctival gene expression. Multiple cytokines and genes involved in the immune response were investigated over time in same individuals. This identified discrete responses that segregated with infection and disease. It challenges current ideas about the mechanisms of control of ocular chlamydial infection which are largely built around laboratory isolates and in vitro cell lines. Because it was possible for the first time to make quantitative measures of bacterial load and natural defence mechanisms which control chlamydial replication in vitro. The findings therefore contribute to overall science base required for the proposed development of a new vaccine. These basic mechanisms also likely underlie disease caused by chlamydiae in the genital tract. Since chlamydial genital tract infection is the most prevalent STI and a major cause of infertility in women the results found here should have wider clinical relevance.</gtr:abstractText><gtr:technicalSummary>The overall aim is to identify an correlate of immunity or disease to naturally acquired ocular infection or disease caused by Chlamydia trachomatis. This important since WHO estimates that at least 600 million people are at risk of infection of which approximately 6 million are blind as a consequence. Immunity to trachoma is still not clearly understood and there is no licensed vaccine or vaccine trail since the 1960s. The objective is to define the immune response at the conjunctival surface (site of infection) during episodes of disease and infection. Ocular chlamydial disease is clinically diagnosed by the appearance of characteristic inflammatory changes and development of lymphoid follicles in the conjunctiva. Nucleic acid amplification tests and relatively non-invasive methods of sampling the conjunctival surface (by swabbing) can be used to quantify the expression of chlamydial and host genes. Using quantitative real-time PCR to detect the presence of C. trachomatis (CT) 16S rRNA and human IL-1?, IL-10, IL-12p40, IFN-? and TNF-? transcripts the immune response at the conjunctival surface was examined in a cohort of children living in a trachoma-endemic village in The Gambia. Elevated cytokine transcript levels were associated with the presence of CT 16S rRNA. Sub-clinical infection (CT infection without clinical signs of disease) elicited an immune response that is pro-inflammatory in nature, with elevations in the transcription of IL-1?, IFN-? and IL-12p40. Clinically apparent infections were associated with the elevation of mRNA for the multifunctional cytokine TNF-? (fibrotic, type 1 inflammatory and regulatory) and the counter regulatory cytokine, IL-10, in addition to the other pro-inflammatory cytokines. A positive correlation between IFN-? transcript levels and the amount of CT 16S rRNA expressed in conjunctiva was found.</gtr:technicalSummary><gtr:fund><gtr:end>2008-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>319964</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0E214318-4774-4F9E-84AE-2DE2D300F1D7</gtr:id><gtr:title>Chlamydia trachomatis ompA variants in trachoma: what do they tell us?</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67e54222fa1397d6528850f3d7c89e25"><gtr:id>67e54222fa1397d6528850f3d7c89e25</gtr:id><gtr:otherNames>Andreasen AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_16510_10_18820750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED1041A9-85C2-4706-8ABE-957328C90899</gtr:id><gtr:title>Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc5d54fd557c51a327ad1d34b5322226"><gtr:id>bc5d54fd557c51a327ad1d34b5322226</gtr:id><gtr:otherNames>Atkinson SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_16510_10_16637741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A1FA202-6EF0-4968-A27B-F00C53536D9C</gtr:id><gtr:title>Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d52ae04398b92d02af5a73b045fe23d"><gtr:id>0d52ae04398b92d02af5a73b045fe23d</gtr:id><gtr:otherNames>Burton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_16510_10_15823382</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB1B5ABB-2787-4732-9CA1-C98C21230D03</gtr:id><gtr:title>Reports on the prevalence of clinical conditions are more convincing when supported by objective evidence.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4b2d1ce3730f260e9d19e65bea7192"><gtr:id>bb4b2d1ce3730f260e9d19e65bea7192</gtr:id><gtr:otherNames>Schachter J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_16510_10_18820749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7041E70D-F64E-4A9B-B394-0909D76BD76B</gtr:id><gtr:title>Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1bb99143189ce9b842790ff92e34e64"><gtr:id>d1bb99143189ce9b842790ff92e34e64</gtr:id><gtr:otherNames>Natividad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>pm_16510_10_17330135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>386F1768-0DC7-4F66-96E3-0D9DC392C861</gtr:id><gtr:title>Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/faec8dd7ad60853da6c238d9c8479200"><gtr:id>faec8dd7ad60853da6c238d9c8479200</gtr:id><gtr:otherNames>Kari L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>pm_16510_10_18199030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7719B983-284E-4A2A-9089-2A48F044E7A9</gtr:id><gtr:title>Long term outcome of trichiasis surgery in the Gambia.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d52ae04398b92d02af5a73b045fe23d"><gtr:id>0d52ae04398b92d02af5a73b045fe23d</gtr:id><gtr:otherNames>Burton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>pm_16510_10_15834088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F10F56E1-BE16-4065-94F7-66FD10C9B040</gtr:id><gtr:title>Household pit latrines as a potential source of the fly Musca sorbens--a one year longitudinal study from The Gambia.</gtr:title><gtr:parentPublicationTitle>Tropical medicine &amp; international health : TM &amp; IH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7295c366266386861d75cd24ba4abd02"><gtr:id>7295c366266386861d75cd24ba4abd02</gtr:id><gtr:otherNames>Emerson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1360-2276</gtr:issn><gtr:outcomeId>pm_16510_10_15960710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B7F027B-BAE1-416C-B432-864799251AEE</gtr:id><gtr:title>Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci.</gtr:title><gtr:parentPublicationTitle>Genes and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1bb99143189ce9b842790ff92e34e64"><gtr:id>d1bb99143189ce9b842790ff92e34e64</gtr:id><gtr:otherNames>Natividad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1466-4879</gtr:issn><gtr:outcomeId>pm_16510_10_15789056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7EFB87B-655B-4756-BED9-0EB2D3DAC067</gtr:id><gtr:title>The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad477705d4c8966434296d200f476ba2"><gtr:id>ad477705d4c8966434296d200f476ba2</gtr:id><gtr:otherNames>Grassly NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_16510_10_19048024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6566F6E-2576-4B22-B00A-E5559D231AFA</gtr:id><gtr:title>Risk factors for active trachoma in The Gambia.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/54f02687a15e5de14772b342776bb860"><gtr:id>54f02687a15e5de14772b342776bb860</gtr:id><gtr:otherNames>Harding-Esch EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>pm_16510_10_18502459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A34407F7-5EE9-4B77-823E-E65C7BB24FC4</gtr:id><gtr:title>Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop?</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d52ae04398b92d02af5a73b045fe23d"><gtr:id>0d52ae04398b92d02af5a73b045fe23d</gtr:id><gtr:otherNames>Burton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>pm_16510_10_16421789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA8A2961-9A51-4780-95CC-1CB0000E7DDD</gtr:id><gtr:title>Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1bb99143189ce9b842790ff92e34e64"><gtr:id>d1bb99143189ce9b842790ff92e34e64</gtr:id><gtr:otherNames>Natividad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16510_10_17947295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4BA0C77-0529-4085-B5D9-669097209EDB</gtr:id><gtr:title>The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation.</gtr:title><gtr:parentPublicationTitle>Bulletin of the World Health Organization</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7295c366266386861d75cd24ba4abd02"><gtr:id>7295c366266386861d75cd24ba4abd02</gtr:id><gtr:otherNames>Emerson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0042-9686</gtr:issn><gtr:outcomeId>pm_16510_10_16917648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68C9AA6B-BA91-4874-B14A-67A49E5F622C</gtr:id><gtr:title>Rapid assessment for prioritisation of trachoma control at community level in one district of the Kaolack Region, Senegal.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc2484905079255d1821ae4005425336"><gtr:id>cc2484905079255d1821ae4005425336</gtr:id><gtr:otherNames>Faye M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>pm_16510_10_16253300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E567CF5D-25DD-43FA-A544-E672A26E36DA</gtr:id><gtr:title>Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d52ae04398b92d02af5a73b045fe23d"><gtr:id>0d52ae04398b92d02af5a73b045fe23d</gtr:id><gtr:otherNames>Burton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_16510_10_14507864</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BE5590D-9724-48E2-941E-3883FFEB7FFD</gtr:id><gtr:title>An index of community ocular Chlamydia trachomatis load for control of trachoma.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d8bcbdf77dcdb23457ce1c51eeec4bb"><gtr:id>5d8bcbdf77dcdb23457ce1c51eeec4bb</gtr:id><gtr:otherNames>Alexander ND</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>pm_16510_10_15653119</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>107DC7AC-C50B-41FD-B7EF-D5485B219E25</gtr:id><gtr:title>Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff24e143c81c957cf784107d5cdc3614"><gtr:id>ff24e143c81c957cf784107d5cdc3614</gtr:id><gtr:otherNames>West SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_16510_10_16214600</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4003B5D-08B6-4127-BC89-F0597E082FB7</gtr:id><gtr:title>The frequency of Chlamydia trachomatis major outer membrane protein-specific CD8+ T lymphocytes in active trachoma is associated with current ocular infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea8450e0533818c13262822f0042102c"><gtr:id>ea8450e0533818c13262822f0042102c</gtr:id><gtr:otherNames>Holland MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_16510_10_16495527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F657117B-1E17-4AAB-BF8E-2F6A2DA8E827</gtr:id><gtr:title>Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c78295d783053b6014b7caa66991841a"><gtr:id>c78295d783053b6014b7caa66991841a</gtr:id><gtr:otherNames>Demba E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>pm_16510_10_15757510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBFD0A6D-5CBC-4811-9832-1EA816FD1DC3</gtr:id><gtr:title>A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d52ae04398b92d02af5a73b045fe23d"><gtr:id>0d52ae04398b92d02af5a73b045fe23d</gtr:id><gtr:otherNames>Burton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>pm_16510_10_16170117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9043FC98-B063-4453-9EDE-815D078ECD37</gtr:id><gtr:title>A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1bb99143189ce9b842790ff92e34e64"><gtr:id>d1bb99143189ce9b842790ff92e34e64</gtr:id><gtr:otherNames>Natividad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>pm_16510_10_16643654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAA97454-3631-456B-B588-47ACD706762F</gtr:id><gtr:title>Sustainability and acceptability of latrine provision in The Gambia.</gtr:title><gtr:parentPublicationTitle>Transactions of the Royal Society of Tropical Medicine and Hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7dc654f2a8c27f047e0e9c669023206a"><gtr:id>7dc654f2a8c27f047e0e9c669023206a</gtr:id><gtr:otherNames>Simms VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0035-9203</gtr:issn><gtr:outcomeId>pm_16510_10_15927217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8707F025-2B6B-4BAD-8DCC-51A4233C1F92</gtr:id><gtr:title>Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a022873c5a77519f54bec8b5073a0251"><gtr:id>a022873c5a77519f54bec8b5073a0251</gtr:id><gtr:otherNames>West ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_16510_10_15623758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64C32E67-1A21-4E2C-89A1-DC28F6DA95C7</gtr:id><gtr:title>Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f03c9e107acbcec2656cc5702a56b10"><gtr:id>7f03c9e107acbcec2656cc5702a56b10</gtr:id><gtr:otherNames>Faal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pm_16510_10_16881731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B8AC63A-6E17-4DE8-83DA-ACFCA8977C56</gtr:id><gtr:title>Targeted treatment of active trachoma.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a45070bd7a7de3c2de2a39132f9c21f"><gtr:id>5a45070bd7a7de3c2de2a39132f9c21f</gtr:id><gtr:otherNames>Mabey D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>pm_16510_10_17299193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35AC81A7-17B6-4445-AA43-6CF6226A59B9</gtr:id><gtr:title>Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3e24cbbef0994c950515347f2b92340"><gtr:id>a3e24cbbef0994c950515347f2b92340</gtr:id><gtr:otherNames>Gower EW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_16510_10_17065486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEB365A5-B165-4C8B-8E75-AC58A3E4BA70</gtr:id><gtr:title>Bacterial infection and trachoma in the gambia: a case control study.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d52ae04398b92d02af5a73b045fe23d"><gtr:id>0d52ae04398b92d02af5a73b045fe23d</gtr:id><gtr:otherNames>Burton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_16510_10_17898263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9055B77C-1DBD-42F3-9A0E-1A884AAFF544</gtr:id><gtr:title>Temporal cytokine gene expression patterns in subjects with trachoma identify distinct conjunctival responses associated with infection.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f03c9e107acbcec2656cc5702a56b10"><gtr:id>7f03c9e107acbcec2656cc5702a56b10</gtr:id><gtr:otherNames>Faal N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>pm_16510_10_16232223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B19A4A2-DA71-40E2-BA86-3584912B0375</gtr:id><gtr:title>Two doses of azithromycin to eliminate trachoma in a Tanzanian community.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a17ff6e354fa130a2cc912967f0c8d3"><gtr:id>2a17ff6e354fa130a2cc912967f0c8d3</gtr:id><gtr:otherNames>Solomon AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_16510_10_18434662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58C9405D-6621-46E3-A2EB-21BC0B390B38</gtr:id><gtr:title>Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31fd15db93cf1bdffa3d57bb941abc7e"><gtr:id>31fd15db93cf1bdffa3d57bb941abc7e</gtr:id><gtr:otherNames>Morison L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>pm_16510_10_15923295</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190081961</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>